|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 3/04 | |
| A61K 31/138 | |||
| A61K 9/00 | |||
| A61K 31/573 |
| (11) | Number of the document | 1921919 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06787329.9 |
| Date of filing the European patent application | 2006-07-13 | |
| (97) | Date of publication of the European application | 2008-05-21 |
| (45) | Date of publication and mention of the grant of the patent | 2012-04-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2006/027405 |
| Date | 2006-07-13 |
| (87) | Number | WO 2007/011743 |
| Date | 2007-01-25 |
| (30) | Number | Date | Country code |
| 699155 P | 2005-07-14 | US | |
| 729531 P | 2005-10-24 | US | |
| 732981 P | 2005-11-03 | US |
| (72) |
DOBAK, John, Daniel, US
|
| (73) |
Lithera, Inc.,
9191 Towne Centre Drive Suite 400 San Diego, California 92122,
US
|
| (54) | SUSTAINED RELEASE ENHANCED LIPOLYTIC FORMULATION FOR REGIONAL ADIPOSE TISSUE TREATMENT |
| SUSTAINED RELEASE ENHANCED LIPOLYTIC FORMULATION FOR REGIONAL ADIPOSE TISSUE TREATMENT |